U.S. patent application number 16/167978 was filed with the patent office on 2019-04-25 for polycyclic aminosilane compounds and making method.
This patent application is currently assigned to Shin-Etsu Chemical Co., Ltd.. The applicant listed for this patent is Shin-Etsu Chemical Co., Ltd.. Invention is credited to Takayuki HONMA, Tohru KUBOTA, Yoichi TONOMURA.
Application Number | 20190119308 16/167978 |
Document ID | / |
Family ID | 63914957 |
Filed Date | 2019-04-25 |
![](/patent/app/20190119308/US20190119308A1-20190425-C00001.png)
![](/patent/app/20190119308/US20190119308A1-20190425-C00002.png)
![](/patent/app/20190119308/US20190119308A1-20190425-C00003.png)
![](/patent/app/20190119308/US20190119308A1-20190425-C00004.png)
![](/patent/app/20190119308/US20190119308A1-20190425-C00005.png)
![](/patent/app/20190119308/US20190119308A1-20190425-C00006.png)
![](/patent/app/20190119308/US20190119308A1-20190425-C00007.png)
![](/patent/app/20190119308/US20190119308A1-20190425-C00008.png)
![](/patent/app/20190119308/US20190119308A1-20190425-C00009.png)
![](/patent/app/20190119308/US20190119308A1-20190425-D00001.png)
![](/patent/app/20190119308/US20190119308A1-20190425-D00002.png)
View All Diagrams
United States Patent
Application |
20190119308 |
Kind Code |
A1 |
TONOMURA; Yoichi ; et
al. |
April 25, 2019 |
POLYCYCLIC AMINOSILANE COMPOUNDS AND MAKING METHOD
Abstract
Polycyclic aminosilane compounds of specific structure are fully
effective for use as silane coupling agents, surface treating
agents, resin additives, paint additives, and adhesives and evolve
little or no low-boiling alcohols during service.
Inventors: |
TONOMURA; Yoichi;
(Joetsu-shi, JP) ; KUBOTA; Tohru; (Joetsu-shi,
JP) ; HONMA; Takayuki; (Joetsu-shi, JP) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
Shin-Etsu Chemical Co., Ltd. |
Tokyo |
|
JP |
|
|
Assignee: |
Shin-Etsu Chemical Co.,
Ltd.
Tokyo
JP
|
Family ID: |
63914957 |
Appl. No.: |
16/167978 |
Filed: |
October 23, 2018 |
Current U.S.
Class: |
1/1 |
Current CPC
Class: |
C07F 7/1888 20130101;
C07F 7/1804 20130101; C07F 7/188 20130101 |
International
Class: |
C07F 7/18 20060101
C07F007/18 |
Foreign Application Data
Date |
Code |
Application Number |
Oct 24, 2017 |
JP |
2017-204952 |
Claims
1. A polycyclic aminosilane compound having the general formula
(1): ##STR00007## wherein R.sup.1 is a substituted or unsubstituted
C.sub.1-C.sub.20 monovalent hydrocarbon group or an organoxy group
having the general formula (2): --OR.sup.8 (2) wherein R.sup.5 is a
substituted or unsubstituted C.sub.1-C.sub.20 monovalent
hydrocarbon group, R.sup.2 to R.sup.5 are each independently a
substituted or unsubstituted C.sub.1-C.sub.20 monovalent
hydrocarbon group, R.sup.6 and R.sup.7 are each independently a
substituted or unsubstituted C.sub.1-C.sub.20 divalent hydrocarbon
group which may contain a heteroatom.
2. A method for preparing the polycyclic aminosilane compound of
claim 1, comprising the steps of: reacting an epoxy-containing
organoxysilane compound having the general formula (3):
##STR00008## wherein R.sup.1, R.sup.3, R.sup.4, R.sup.5 and R.sup.7
are as defined above, R.sup.9 is a substituted or unsubstituted
C.sub.1-C.sub.20 monovalent hydrocarbon group, with a
hydroxyl-containing amine compound having the general formula (4):
##STR00009## wherein R.sup.2 and R.sup.6 are as defined above, and
distilling the resulting reaction mixture.
3. The method of claim 2 wherein the distilling step is carried out
in the presence of a basic catalyst or acid catalyst.
4. The method of claim 2 wherein in the distilling step, a compound
having a higher boiling point than the polycyclic aminosilane
compound of formula (1) is used as a solvent.
Description
CROSS-REFERENCE TO RELATED APPLICATION
[0001] This non-provisional application claims priority under 35
U.S.C. .sctn. 119(a) on Patent Application No. 2017-204952 filed in
Japan on Oct. 24, 2017, the entire contents of which are hereby
incorporated by reference.
TECHNICAL FIELD
[0002] This invention relates to polycyclic aminosilane compounds
and a method for preparing the same. The polycyclic aminosilane
compounds are useful as silane coupling agents, surface treating
agents, resin additives, paint additives, and adhesives.
BACKGROUND ART
[0003] Silane compounds having an amino group are useful as silane
coupling agents, surface treating agents, resin additives, paint
additives, and adhesives. Known silane compounds having an amino
group include organoxysilane compounds having a primary amino group
such as aminopropyltrimethoxysilane, organoxysilane compounds
having a secondary amino group such as
N-phenylaminopropyltrimethoxysilane, and organoxysilane compounds
having a tertiary amino group such as
dimethylaminopropyltrimethoxysilane.
[0004] These silane compounds have only one functional or amino
group per molecule. For this reason, they sometimes insufficiently
develop effects due to functionality introduction when used as
silane coupling agents, surface treating agents, resin additives,
paint additives, and adhesives.
[0005] To solve the outstanding problem, Patent Documents 1 and 3
propose tertiary aminosilane compounds having an intramolecular
organoxysilyl group and Patent Document 2 discloses a secondary
aminosilane compounds having an intramolecular organoxysilyl group.
Since these compounds react with moisture to form a hydroxyl group
in addition to the original amino group, the effects due to
functionality introduction become greater. These compounds are also
regarded as less environmental load-providing compounds because the
intramolecular organoxy moiety does not form low-boiling alcohols
such as methanol and ethanol upon reaction with moisture.
CITATION LIST
[0006] Patent Document 1: JP-A 2010-120925
[0007] Patent Document 2: JP-A 2010-285406
[0008] Patent Document 3: JP-A 2014-001152
DISCLOSURE OF INVENTION
[0009] In the current applications of silane compounds including
silane coupling agents, surface treating agents, resin additives,
paint additives, and adhesives, silane compounds capable of
exerting greater additive effects are required in compliance with
the diversification of the intended purpose. In this context, the
compounds of Patent Documents 1 to 3, which possess per molecule
one amino group and one hydroxyl group resulting from reaction with
moisture, exert rather less additive effects.
[0010] In conjunction with environmental problems deeply related to
the global greenhouse effects and health impacts, one of the
important themes is a saving of volatile organic compounds.
Engineers made efforts to achieve a saving of volatile organic
compounds by reducing the amount of low-boiling alcohols evolving
from organoxysilane compounds. There is a desire to have a silane
compound evolving a smaller amount of low-boiling alcohol.
[0011] An object of the invention is to provide a silane compound
which exerts greater additive effects when used as silane coupling
agents, surface treating agents, resin additives, paint additives,
and adhesives, and which evolves a minimal amount of low-boiling
alcohol, and a method for preparing the same.
[0012] The inventors have found that a polycyclic aminosilane
compound of specific structure exerts greater additive effects when
used as silane coupling agents, surface treating agents, resin
additives, paint additives, and adhesives, and evolves little or no
low-boiling alcohol.
[0013] In one aspect, the invention provides a polycyclic
aminosilane compound having the general formula (1).
##STR00001##
Herein R.sup.1 is a substituted or unsubstituted C.sub.1-C.sub.20
monovalent hydrocarbon group or an organoxy group having the
general formula (2):
--OR.sup.8 (2)
wherein R.sup.8 is a substituted or unsubstituted C.sub.1-C.sub.20
monovalent hydrocarbon group. R.sup.2 to R.sup.5 are each
independently a substituted or unsubstituted C.sub.1-C.sub.20
monovalent hydrocarbon group. R.sup.6 and R.sup.7 are each
independently a substituted or unsubstituted C.sub.1-C.sub.20
divalent to hydrocarbon group which may contain a heteroatom.
[0014] In another aspect, the invention provides a method for
preparing the polycyclic aminosilane compound defined above,
comprising the steps of reacting an epoxy-containing organoxysilane
compound having the general formula (3) with a hydroxyl-containing
amine compound having the general formula (4), and distilling the
resulting reaction mixture.
##STR00002##
Herein R.sup.1, R.sup.3, R.sup.4, R.sup.5 and R.sup.7 are as
defined above, R.sup.9 is a substituted or unsubstituted
C.sub.1-C.sub.20 monovalent hydrocarbon group.
##STR00003##
Herein R.sup.2 and R.sup.6 are as defined above.
[0015] Preferably, the distilling step is carried out in the
presence of a basic catalyst or acid catalyst. Also preferably, in
the distilling step, a compound having a higher boiling point than
the polycyclic aminosilane compound of formula (1) is used as a
solvent.
Advantageous Effects of Invention
[0016] The polycyclic aminosilane compounds of the invention exert
great additive effects and evolve little or no low-boiling alcohols
during service. They are useful as silane coupling agents, surface
treating agents, resin additives, paint additives, and
adhesives.
BRIEF DESCRIPTION OF DRAWINGS
[0017] FIGS. 1 and 2 are diagrams showing .sup.1H-NMR and IR
spectra of
5-aza-2,9,13-trioxa-1-sila-1,5-dimethylbicyclo[5.5.1]tridecane in
Example 1, respectively.
[0018] FIGS. 3 and 4 are diagrams showing .sup.1H-NMR and IR
spectra of
5-aza-2,9,13-trioxa-1-sila-5-ethyl-1-methylbicyclo[5.5.1]tridecane
in Example 5, respectively.
[0019] FIGS. 5 and 6 are diagrams showing .sup.1H-NMR and IR
spectra of
5-aza-2,9,13-trioxa-1-sila-5-(N,N-diethylamino)ethyl-1-methylbicyclo[5.5.-
1]tridecane in Example 6, respectively.
DESCRIPTION OF PREFERRED EMBODIMENTS
[0020] The notation (Cn-Cm) means a group containing from n to m
carbon atoms per group.
[0021] One embodiment of the invention is a polycyclic aminosilane
compound having the general formula (1).
##STR00004##
[0022] In formula (1), R.sup.1 is a substituted or unsubstituted
C.sub.1-C.sub.20, preferably C.sub.1-C.sub.10, more preferably
C.sub.1-C.sub.5, monovalent hydrocarbon group or an organoxy group
having the general formula (2):
--OR.sup.8 (2)
wherein R.sup.8 is a substituted or unsubstituted C.sub.1-C.sub.20,
preferably C.sub.1-C.sub.10, more preferably C.sub.1-C.sub.5,
monovalent hydrocarbon group. R.sup.2 to R.sup.5 are each
independently a substituted or unsubstituted C.sub.1-C.sub.20,
preferably C.sub.1-C.sub.10, more preferably C.sub.1-C.sub.5,
monovalent hydrocarbon group. R.sup.6 and R.sup.7 are each
independently a substituted or unsubstituted C.sub.1-C.sub.20,
preferably C.sub.1-C.sub.10, more preferably C.sub.1-C.sub.5,
divalent hydrocarbon group which may contain a heteroatom.
[0023] The substituted or unsubstituted C.sub.1-C.sub.20 monovalent
hydrocarbon group, represented by R.sup.1 to R.sup.5 and R.sup.8,
may be straight, branched or cyclic. Examples include alkyl,
alkenyl, aryl and aralkyl groups, and specifically, straight alkyl
groups such as methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl,
octyl, decyl, dodecyl, tetradecyl, hexadecyl, octadecyl and
eicosyl; branched alkyl groups such as isopropyl, isobutyl,
sec-butyl, tert-butyl, thexyl and 2-ethylhexyl; cyclic alkyl groups
such as cyclopentyl and cyclohexyl; alkenyl groups such as vinyl,
allyl, butenyl and pentenyl; aryl groups such as phenyl and tolyl;
and aralkyl groups such as benzyl. Inter alia, C.sub.1-C.sub.3
straight alkyl groups such as methyl, ethyl and propyl, and
C.sub.1-C.sub.5 alkenyl groups such as allyl, butenyl and pentenyl
are preferred for the availability of reactants and the utility of
products.
[0024] Also included are substituted forms of the foregoing
hydrocarbon groups in which one or more or even all hydrogen atoms
are substituted by other substituents. Suitable substituents
include C.sub.1-C.sub.3 alkoxy groups such as methoxy, ethoxy and
(iso)propoxy; halogen atoms such as fluorine, chlorine, bromine and
iodine; cyano groups, amino groups, C.sub.2-C.sub.10 acyl groups,
trichlorosilyl groups, and trialkylsilyl, dialkylmonochlorosilyl,
monoalkyldichlorosilyl, trialkoxysilyl, dialkylmonoalkoxysilyl and
mono alkyldialkoxysilyl groups in which each alkyl or alkoxy moiety
has 1 to 5 carbon atoms.
[0025] Examples of the optionally heteroatom-containing
C.sub.1-C.sub.20 divalent hydrocarbon group, represented by R.sup.6
and R.sup.7, include alkylene groups such as methylene, ethylene,
methylethylene (propylene), trimethylene, methylpropytlene,
tetramethylene, hexamethylene, octamethylene, decamethylene and
isobutylene; arylene groups such as phenylene and methylphenylene;
aralkylene groups such as ethylenephenylene and
ethylenephenylenemethylene; and oxaalkylene groups such as
2-oxapropylene and 2-oxapentylene. It is preferred for the
availability of reactants and the utility of products that R.sup.6
be a C.sub.1-C.sub.5 alkylene group and R.sup.7 be a
C.sub.1-C.sub.5 oxaalkylene group.
[0026] Examples of the polycyclic aminosilane compound having
formula (1) include: [0027]
5-aza-2,9,11-trioxa-1-sila-1,5-dimethylbicyclo[5.3.1]undecane,
[0028]
5-aza-2,9,11-trioxa-1-sila-1-methoxy-5-methylbicyclo[5.3.1]undecane,
[0029]
5-aza-2,9,11-trioxa-1-sila-1-ethoxy-5-methylbicyclo[5.3.1]undecane-
, [0030]
5-aza-2,9,11-trioxa-1-sila-5-methyl-1-methylbicyclo[5.3.1]undecan-
e, [0031]
5-aza-2,9,11-trioxa-1-sila-5-ethyl-1-methoxybicyclo[5.3.1]undeca-
ne, [0032]
5-aza-2,9,11-trioxa-1-sila-1-ethoxy-5-ethylbicyclo[5.3.1]undeca-
ne, [0033]
5-aza-2,9,11-trioxa-1-sila-1,3,5-trimethylbicyclo[5.3.1]undecan- e,
[0034]
5-aza-2,9,11-trioxa-1-sila-1-methoxy-3,5-dimethylbicyclo[5.3.1]u-
ndecane, [0035]
5-aza-2,9,11-trioxa-1-sila-1-ethoxy-3,5-dimethylbicyclo[5.3.1]undecane,
[0036]
5-aza-2,9,11-trioxa-1-sila-5-ethyl-1,3-dimethylbicyclo[5.3.1]undec-
ane, [0037]
5-aza-2,9,11-trioxa-1-sila-5-ethyl-1-methoxy-3-methylbicyclo[5.3.1]undeca-
ne, [0038]
5-aza-2,9,11-trioxa-1-sila-1-ethoxy-5-ethyl-3-methylbicyclo[5.3-
.1]undecane, [0039]
6-aza-2,10,12-trioxa-1-sila-1,6-dimethylbicyclo[6.3.1]dodecane,
[0040]
6-aza-2,10,12-trioxa-1-sila-1-methoxy-6-methylbicyclo[6.3.1]dodecane,
[0041]
6-aza-2,10,12-trioxa-1-sila-1-ethoxy-6-methylbicyclo[6.3.1]dodecan-
e, [0042]
6-aza-2,10,12-trioxa-1-sila-6-ethyl-1-methylbicyclo[6.3.1]dodeca-
ne, [0043]
6-aza-2,10,12-trioxa-1-sila-6-ethyl-1-methoxybicyclo[6.3.1]dode-
cane, [0044]
6-aza-2,10,12-trioxa-1-sila-1-ethoxy-6-ethylbicyclo[6.3.1]dodecane,
[0045]
6-aza-2,10,12-trioxa-1-sila-1,3,6-trimethylbicyclo[6.3.1]dodecane,
[0046]
6-aza-2,10,12-trioxa-1-sila-1-methoxy-3,6-dimethylbicyclo[6.3.1]do-
decane, [0047]
6-aza-2,10,12-trioxa-1-sila-1-ethoxy-3,6-dimethylbicyclo[6.3.1]dodecane,
[0048]
6-aza-2,10,12-trioxa-1-sila-6-ethyl-1,3-dimethylbicyclo[6.3.1]dode-
cane, [0049]
6-aza-2,10,12-trioxa-1-sila-6-ethyl-1-methoxy-3-methylbicyclo[6.3.1]dodec-
ane, [0050]
6-aza-2,10,12-trioxa-1-sila-1-ethoxy-6-ethyl-3-methylbicyclo[6.3.1]dodeca-
ne, [0051]
5-aza-2,9,13-trioxa-1-sila-1,5-dimethylbicyclo[5.5.1]tridecane,
[0052]
5-aza-2,9,13-trioxa-1-sila-1-methoxy-5-methylbicyclo[5.5.1]trideca-
ne, [0053]
5-aza-2,9,13-trioxa-1-sila-1-ethoxy-5-methylbicyclo[5.5.1]tride-
cane, [0054]
5-aza-2,9,13-trioxa-1-sila-5-ethyl-1-methylbicyclo[5.5.1]tridecane,
[0055]
5-aza-2,9,13-trioxa-1-sila-5-ethyl-1-methoxybicyclo[5.5.1]tridecan-
e, [0056]
5-aza-2,9,13-trioxa-1-sila-1-ethoxy-5-ethylbicyclo[5.5.1]trideca-
ne, [0057]
5-aza-2,9,13-trioxa-1-sila-5-(N,N-dimethylamino)ethyl-1-methylb-
icyclo[5.5.1]tridecane, [0058]
5-aza-2,9,13-trioxa-1-sila-5-(N,N-dimethylamino)ethyl-1-methoxybicyclo[5.-
5.1]tridecane, [0059]
5-aza-2,9,13-trioxa-1-sila-1-ethoxy-5-(N,N-dimethylamino)ethylbicyclo[5.5-
.1]tridecane, [0060]
5-aza-2,9,13-trioxa-1-sila-5-(N,N-diethylamino)ethyl-1-methylbicyclo[5.5.-
1]tridecane, [0061]
5-aza-2,9,13-trioxa-1-sila-5-(N,N-diethylamino)ethyl-1-methoxybicyclo[5.5-
.1]tridecane, [0062]
5-aza-2,9,13-trioxa-1-sila-1-ethoxy-5-(N,N-diethylamino)ethylbicyclo[5.5.-
1]tridecane, [0063]
5-aza-2,9,13-trioxa-1-sila-1,3,5-trimethylbicyclo[5.5.1]tridecane,
[0064]
5-aza-2,9,13-trioxa-1-sila-1-methoxy-3,5-dimethylbicyclo[5.5.1]tridecane,
[0065]
5-aza-2,9,13-trioxa-1-sila-1-ethoxy-3,5-dimethylbicyclo[5.5.1]trid-
ecane, [0066]
5-aza-2,9,13-trioxa-1-sila-5-ethyl-1,3-dimethylbicyclo[5.5.1]tridecane,
[0067]
5-aza-2,9,13-trioxa-1-sila-5-ethyl-1-methoxy-3-methylbicyclo[5.5.1-
]tridecane, [0068]
5-aza-2,9,13-trioxa-1-sila-1-ethoxy-5-ethyl-3-methylbicycio[5.5.1]trideca-
ne, [0069]
5-aza-2,9,13-trioxa-1-sila-5-(N,N-dimethylamino)ethyl-1,3-dimet-
hylbicyclo[5.5.1]tridecane, [0070]
5-aza-2,9,13-trioxa-1-sila-5-(N,N-dimethylamino)ethyl-1-methoxy-3-methylb-
icyclo-[5.5.1]tridecane, [0071]
5-aza-2,9,13-trioxa-1-sila-1-ethoxy-5-(N,N-dimethylamino)ethyl-3-methylbi-
cyclo-[5.5.1]tridecane, [0072]
5-aza-2,9,13-trioxa-1-sila-5-(N,N-diethylamino)ethyl-1,3-dimethylbicyclo[-
5.5.1]tridecane, [0073]
5-aza-2,9,13-trioxa-1-sila-5-(N,N-diethylamino)ethyl-1-methoxy-3-methylbi-
cyclo-[5.5.1]tridecane, [0074]
5-aza-2,9,13-trioxa-1-sila-1-ethoxy-5-(N,N-diethylamino)ethyl-3-methylbic-
yclo-[5.5.1]tridecane, [0075]
6-aza-2,10,14-trioxa-1-sila-1,6-dimethylbicyclo[6.5.1]tetradecane,
[0076]
6-aza-2,10,14-trioxa-1-sila-1-methoxy-6-methylbicyclo[6.5.1]tetradecane,
[0077]
6-aza-2,10,14-trioxa-1-sila-1-ethoxy-6-methylbicyclo[6.5.1]tetrade-
cane, [0078]
6-aza-2,10,14-trioxa-1-sila-6-ethyl-1-methylbicyclo[6.5.1]tetradecane,
[0079]
6-aza-2,10,14-trioxa-1-sila-6-ethyl-1-methoxybicyclo[6.5.1]tetrade-
cane, [0080]
6-aza-2,10,14-trioxa-1-sila-1-ethoxy-6-ethylbicyclo[6.5.1]tetradecane,
[0081]
6-aza-2,10,14-trioxa-1-sila-6-(N,N-dimethylamino)ethyl-1-methylbic-
yclo[6.5.1]tetradecane, [0082]
6-aza-2,10,14-trioxa-1-sila-6-(N,N-dimethylamino)ethyl-1-methoxybicyclo[6-
.5.1]tetradecane, [0083]
6-aza-2,10,14-trioxa-1-sila-1-ethoxy-6-(N,N-dimethylamino)ethylbicyclo[6.-
5.1]tetradecane, [0084]
6-aza-2,10,14-trioxa-1-sila-6-(N,N-diethylamino)ethyl-1-methylbicyclo[6.5-
.1]tetradecane, [0085]
6-aza-2,10,14-trioxa-1-sila-6-(N,N-diethylamino)ethyl-1-methoxybicyclo[6.-
5.1]tetradecane, [0086]
6-aza-2,10,14-trioxa-1-sila-1-ethoxy-6-(N,N-diethylamino)ethylbicyclo[6.5-
.1]tetradecane, [0087]
6-aza-2,10,14-trioxa-1-sila-1,3,6-trimethylbicyclo[6.5.1]tetradecane,
[0088]
6-aza-2,10,14-trioxa-1-sila-1-methoxy-3,6-dimethylbicyclo[6.5.1]te-
tradecane, [0089]
6-aza-2,10,14-trioxa-1-sila-1-ethoxy-3,6-dimethylbicyclo[6.5.1]tetradecan-
e, [0090]
6-aza-2,10,14-trioxa-1-sila-6-ethyl-1,3-dimethylbicyclo[6.5.1]te-
tradecane, [0091]
6-aza-2,10,14-trioxa-1-sila-6-ethyl-1-methoxy-3-methylbicyclo[6.5.1]tetra-
decane, [0092]
6-aza-2,10,14-trioxa-1-sila-1-ethoxy-6-ethyl-3-methylbicyclo[6.5.1]tetrad-
ecane, [0093]
6-aza-2,10,14-trioxa-1-sila-6-(N,N-dimethylamino)ethyl-1,3-dimethylbicycl-
o-[6.5.1]tetradecane, [0094]
6-aza-2,10,14-trioxa-1-sila-6-(N,N-dimethylamino)ethyl-1-methoxy-3-methyl-
bicyclo-[6.5.1]tetradecane, [0095]
6-aza-2,10,14-trioxa-1-sila-1-ethoxy-6-(N,N-dimethylamino)ethyl-3-methylb-
icyclo-[6.5.1]tetradecane, [0096]
6-aza-2,10,14-trioxa-1-sila-6-(N,N-diethylamino)ethyl-1,3-dimethylbicyclo-
[6.5.1]tetradecane, [0097]
6-aza-2,10,14-trioxa-1-sila-6-(N,N-diethylamino)ethyl-1-methoxy-3-methylb-
icyclo-[6.5.1]tetradecane, and [0098]
6-aza-2,10,14-trioxa-1-sila-1-ethoxy-6-(N,N-diethylamino)ethyl-3-methylbi-
cyclo-[6.5.1]tetradecane.
[0099] The polycyclic aminosilane compound having formula (1) may
be prepared, for example, by a method comprising the steps of
reacting an epoxy-containing organoxysilane compound having the
general formula (3) with a hydroxyl-containing amine compound
having the general formula (4), and distilling the resulting
reaction mixture.
##STR00005##
Herein R.sup.1 to R.sup.7 are as defined above, R.sup.9 is a
substituted or unsubstituted C.sub.1-C.sub.20, preferably
C.sub.1-C.sub.10, more preferably C.sub.1-C.sub.5, monovalent
hydrocarbon group.
[0100] In formula (3), examples of the substituted or unsubstituted
C.sub.1-C.sub.20 monovalent hydrocarbon group R.sup.9 are as
exemplified above for R.sup.1.
[0101] Examples of the epoxy-containing organoxysilane compound
having formula (3) include glycidoxymethyltrimethoxysilane,
glycidoxymethyldimethoxymethylsilane,
glycidoxymethyltriethoxysilane,
glycidoxymethyldiethoxymethylsilane,
3-glycidoxypropyltrimethoxysilane,
3-glycidoxypropyldimethoxymethylsilane,
3-glycidoxypropyltriethoxysilane, and
3-glycidoxypropyldiethoxymethylsilane.
[0102] Examples of the hydroxyl-containing amine compound having
formula (4) include methylethanolamine, ethylethanolamine,
methylisopropanolamine, ethylisopropanolamine, to
(N,N-dimethylaminoethyl)ethanolamine,
(N,N-diethylaminoethyl)ethanolamine,
(N,N-dimethylaminoethyl)isopropanolamine, and
(N,N-diethylaminoethyl)isopropanolamine.
[0103] While the epoxy-containing organoxysilane compound having
formula (3) and the hydroxyl-containing amine compound having
formula (4) may be mixed in any desired ratio, it is preferred from
the standpoints of reactivity and productivity to mix 1 mole of the
compound having formula (3) with 0.2 to 5.0 moles, more preferably
0.5 to 2.0 moles of the compound having formula (4).
[0104] The reaction may take place either in the presence or
absence of a catalyst. A catalyst may be used for the purpose of
accelerating the reaction rate. Suitable catalysts include basic
catalysts such as sodium hydroxide, potassium hydroxide, sodium
methoxide, sodium ethoxide, sodium methoxide in methanol, and
sodium ethoxide in ethanol; acid catalysts, for example, sulfonic
acids such as methanesulfonic acid, benzenesulfonic acid,
toluenesulfonic acid, dodecylbenzenesulfonic acid, and
trifluoromethanesulfonic acid, mineral acids such as sulfuric acid,
hydrochloric acid and nitric acid, and salts of the foregoing
acids. While the catalyst may be used in any desired amount, it is
preferred from the standpoints of reactivity and productivity to
use 0.0001 to 0.2 mole, more preferably 0.001 to 0.1 mole of the
catalyst per mole of the epoxy-containing organoxysilane compound
having formula (3).
[0105] The reaction may take place either in the presence or
absence of a solvent. When used, suitable solvents include
hydrocarbon solvents such as pentane, hexane, cyclohexane, heptane,
isooctane, benzene, toluene and xylene; ether solvents such as
diethyl ether, tetrahydrofuran, and dioxane; ester solvents such as
ethyl acetate and butyl acetate; aprotic polar solvents such as
acetonitrile, N,N-dimethylformamide and N-methylpyrrolidone;
chlorinated hydrocarbon solvents such as dichloromethane and
chloroform; alcohol solvents such as methanol, ethanol, 1-propanol
and 2-propanol, which may be used alone or in admixture.
[0106] The reaction proceeds as shown by the following scheme.
First, the epoxy-containing organoxysilane compound having formula
(3) reacts with the hydroxyl-containing amine compound having
formula (4) to form a hydroxyl-containing aminoorganosilane
compound. In the subsequent step of distilling the reaction
solution containing the hydroxyl-containing aminoorganoxysilane
compound, intramolecular dealcoholization cyclization occurs to
form the desired polycyclic aminosilane compound.
##STR00006##
[0107] The distillation may be performed by any conventional
techniques. Preferably distillation is performed in the presence of
a basic or acid catalyst in order to accelerate the rate of
dealcoholization reaction, and also for the purpose of cracking a
high molecular weight compound resulting from intramolecular
dealcoholization cyclization in the reaction solution to convert it
to the desired polycyclic aminosilane compound. Sometimes, the
reaction solution thickens or even solidifies due to formation of
the high molecular weight compound. To avoid this phenomenon, a
solvent is preferably added to the reaction solution prior to the
distillation. More preferably a solvent having a higher boiling
point than the desired polycyclic aminosilane compound is added
prior to the distillation.
[0108] Examples of the catalyst which is preferably present during
distillation include basic catalysts such as sodium hydroxide,
potassium hydroxide, sodium methoxide, sodium ethoxide, sodium
methoxide in methanol, and sodium ethoxide in ethanol; acid
catalysts, for example, sulfonic acids such as methanesulfonic
acid, benzenesulfonic acid, toluenesulfonic acid,
dodecylbenzenesulfonic acid, and trifluoromethanesulfonic acid,
mineral acids such as sulfuric acid, hydrochloric acid and nitric
acid, and salts of the foregoing acids. While the catalyst may be
used in any desired amount, it is preferred from the standpoints of
reactivity and productivity to use 0.0001 to 0.2 mole, more
preferably 0.001 to 0.1 mole of the catalyst per mole of the
epoxy-containing organoxysilane compound having formula (3).
[0109] The solvent which is preferably present during distillation
may be selected as appropriate depending on the boiling point of
the desired compound. Suitable solvents include hydrocarbon
solvents such as pentane, hexane, cyclohexane, heptane, isooctane,
decane, tridecane, octadecane, eicosane, benzene, toluene, xylene
and dodecylbenzene; ether solvents such as diethyl ether,
tetrahydrofuran, dioxane and diphenyl ether; ester solvents such as
ethyl acetate, butyl acetate, methyl stearate, and methyl oleate;
aprotic polar solvents such as acetonitrile, N,N-dimethylformamide
and N-methylpyrrolidone; chlorinated hydrocarbon solvents such as
dichloromethane and chloroform; alcohol solvents such as methanol,
ethanol, 1-propanol, 2-propanol, 1-decanol, 1-octadecanol,
2-hexyl-1-decanol, oleyl alcohol and 1-docosanol, which may be used
alone or in admixture.
EXAMPLE
[0110] Examples of the invention are given below by way of
illustration and not by way of limitation.
[0111] It is noted that .sup.1H-NMR spectroscopy uses 600 MHz and
deuterated chloroform solvent and IR spectroscopy is by D-ATR.
Example 1
[0112] A flask equipped with a stirrer, reflux condenser, dropping
funnel and thermometer was charged with 94.6 g (1.3 mol) of
methylethanolamine and 76.8 g of methanol and heated at 60.degree.
C. After the internal temperature became constant, 264.4 g (1.2
mol) of 3-glycidoxypropyldimethoxymethylsilane was added dropwise
over 2 hours, and stirring was continued at the temperature for 2
hours. Afterward 4.6 g of a methanol solution of 28 wt % sodium
methoxide and 300 g of 1-octadecanol were added to the reaction
solution, which was distilled. There was collected 213.2 g of a
fraction at a boiling point 114-116.degree. C./0.4 kPa.
[0113] On analysis by mass, .sup.1H-NMR and IR spectroscopy, the
fraction was identified to be
5-aza-2,9,13-trioxa-1-sila-1,5-dimethylbicyclo[5.5.1]tridecane.
FIG. 1 shows .sup.1H-NMR spectrum and FIG. 2 shows IR spectrum.
[0114] Mass Spectrum
[0115] m/z 231, 216, 188, 174, 158, 58
Example 2
[0116] The reaction and distillation steps in Example 1 were
repeated aside from adding 1-octadecane instead of 1-octadecanol
prior to distillation. There was collected 205.3 g of a fraction at
a boiling point 114-116.degree. C./0.4 kPa. On analysis by mass,
.sup.1H-NMR and IR spectroscopy, the fraction was found to be
identical with Example 1, i.e.,
5-aza-2,9,13-trioxa-1-sila-1,5-dimethylbicyclo[5.5.1]tridecane.
Example 3
[0117] The reaction and distillation steps in Example 1 were
repeated aside from adding oleyl alcohol instead of 1-octadecanol
prior to distillation. There was collected 213.5 g of a fraction at
a boiling point 114-116.degree. C./0.4 kPa. On analysis by mass,
.sup.1H-NMR and IR spectroscopy, the fraction was found to be
identical with Example 1, i.e.,
5-aza-2,9,13-trioxa-1-sila-1,5-dimethylbicyclo[5.5.1]tridecane.
Example 4
[0118] The reaction and distillation steps in Example 1 were
repeated aside from using 298.1 g of
3-glycidoxypropyldiethoxymethylsilane instead of 264.4 g of
3-glycidoxypropyldimethoxymethylsilane and 110.6 g of ethanol
instead of 76.8 g of methanol. There was collected 215.5 g of a
fraction at a boiling point 114-116.degree. C./0.4 kPa. On analysis
by mass, .sup.1H-NMR and IR spectroscopy, the fraction was found to
be identical with Example 1, i.e.,
5-aza-2,9,13-trioxa-1-sila-1,5-dimethylbicyclo[5.5.1]tridecane.
Example 5
[0119] A flask equipped with a stirrer, reflux condenser, dropping
funnel and thermometer was charged with 112.3 g (1.3 mol) of
ethylethanolamine and 76.8 g of methanol and heated at 60.degree.
C. After the internal temperature became constant, 264.4 g (1.2
mol) of 3-glycidoxypropyldimethoxymethylsilane was added dropwise
over 2 hours, and stirring was continued at the temperature for 2
hours. Afterward 4.6 g of a methanol solution of 28 wt % sodium
methoxide and 300 g of 1-octadecanol were added to the reaction
solution, which was distilled. There was collected 248.2 g of a
fraction at a boiling point 126-127.degree. C./0.4 kPa.
[0120] On analysis by mass, .sup.1H-NMR and IR spectroscopy, the
fraction was identified to be
5-aza-2,9,13-trioxa-1-sila-5-ethyl-1-methylbicyclo[5.5.1]tridecane.
FIG. 3 shows .sup.1H-NMR spectrum and FIG. 4 shows IR spectrum.
[0121] Mass Spectrum
[0122] m/z 245, 230, 200, 172, 145, 72
Example 6
[0123] A flask equipped with a stirrer, reflux condenser, dropping
funnel and thermometer was charged with 33.7 g (0.21 mol) of
(N,N-diethylaminoethyl)ethanolamine and 12.8 g of methanol and
heated at 60.degree. C. After the internal temperature became
constant, 44.1 g (0.2 mol) of
3-glycidoxypropyldimethoxymethylsilane was added dropwise over 2
hours, and stirring was continued at the temperature for 2 hours.
Afterward 0.77 g of a methanol solution of 28 wt % sodium methoxide
and 130 g of 1-docosanol were added to the reaction solution, which
was distilled. There was collected 44.2 g of a fraction at a
boiling point 141-150.degree. C./0.1 kPa.
[0124] On analysis by mass, .sup.1H-NMR and IR spectroscopy, the
fraction was identified to be
5-aza-2,9,13-trioxa-1-sila-5-(N,N-diethylamino)ethyl-1-methylbicyclo[5.5.-
1]tridecane. FIG. 5 shows .sup.1H-NMR spectrum and FIG. 6 shows IR
spectrum.
[0125] Mass Spectrum
[0126] m/z 230, 143, 101, 100, 86, 58
[0127] Japanese Patent Application No. 2017-204952 is incorporated
herein by reference.
[0128] Although some preferred embodiments have been described,
many modifications and variations may be made thereto in light of
the above teachings. It is therefore to be understood that the
invention may be practiced otherwise than as specifically described
without departing from the scope of the appended claims.
* * * * *